The PDZ domain is a modular protein-interaction domain composed of ~100 amino acids and was first identified in the Drosophila Discs large (Dlg) protein that plays a key role in the differentiation of retinal epithelial cells in the fruit fly. Subsequent studies showed that the mammalian neuronal postsynaptic protein PSD-95 and the adherens junction protein ZO-1 contained a highly homologous domain, thereby defining the domain as a PSD-95, Dlg, and ZO-1 homology (PDZ) domain. Analysis of the human genome suggests the existence of 540 distinct PDZ domains in 306 different proteins, making the PDZ domain one of the most prevalent modular domains found in human proteins (39, 57) . Presence of multiple PDZ domains as well as other protein-interaction domains (e.g., Src homology 2 domain, phosphotyrosine-binding domain, actin-binding, sterile alpha motif, coiled-coil, etc.) within a single polypeptide further expands the functional diversity of protein scaffolds that are able to nucleate or assemble large multiprotein complexes at specific sites or organelles in mammalian cells.
This review focuses on Na + /H + exchanger (NHE) regulatory factors (NHERFs), the PDZ domain-containing products of two different mammalian genes. NHERF-1 is also known as ezrin-binding phosphoprotein of 50 kDa (EBP50) (45) , and NHERF-2 was also identified as NHE-3 kinase A-regulatory protein (E3KARP) (68) , tyrosine kinase activator-1 (TKA1), and sex-determining region of the Y chromosome (SRY-1) -interacting protein-1 (SIP-1) (41). Both NHERFs share structural homology within two tandem PDZ domains and a COOH-terminal ERM-binding domain that binds all members of the ezrinradixin-moesin-merlin family of cytoskeletal proteins (68) . In this regard, NHERFs display the structural and functional properties of many other PDZ proteins located at or near the cell surface. However, the number of NHERF targets thus far identified far exceeds that for any other PDZ protein. Thus studies of NHERF functions have provided critical insights into the diverse roles rable PDZ domain (PDZ-I or PDZ-II) in both NHERF proteins, whereas other targets bind only one of the two isoforms (Table 1) under basal or unstimulated conditions. However, following activation by ␤ 2 -AR agonists, NHERF-1 is rapidly recruited and binds the COOH terminus of ␤ 2 -AR (14) . Yet other targets, such as the -opioid receptor and the platelet-derived growth factor receptor (PDGFR), bind NHERF-1 in the absence of ligands, but this association is greatly strengthened following receptor stimulation by appropriate hormone or growth factor (30, 35). Why NHERF binds some GPCRs constitutively and others in a ligand-regulated manner is still unclear, but a growing speculation is that specific pools of receptor devoid of other competing ligands, such as G proteins, arrestins, and G protein-coupled receptor kinases (GRKs), may be particularly well suited to binding NHERFs, which may serve a function distinct from second-messenger signaling. Consistent with this notion, the association of parathyroid hormone receptor (PTH1R) with either NHERF-2 (34) or NHERF-1 (33) impairs this receptor's ability to elevate intracellular cAMP. Remarkably, the NHERF-bound PTH1R more effectively promotes phosphoinositide turnover (34) . Thus NHERF-1 may switch PTH1R signaling from PKA to PKC and modulate the physiological functions of ion transporters and other proteins in the kidney and other tissues.
Interestingly, NHERF-2 uniquely binds ␣-actinin in a calcium-dependent manner (22) . Because neither NHERF-2 nor ␣-actinin is a recognized calcium-binding protein, the effects of calcium may be indirect, perhaps acting via the rearrangement of the actin cytoskeleton that is bound by both proteins. This in turn is thought to facilitate the downregulation or internalization of targets such as NHE3 (22) . This further emphasizes the experimental difficulties in identifying many NHERF targets, because prior knowledge of the physiological conditions that promote their association with NHERF is essential to decipher the function of these cellular complexes.
Covalent modification of NHERF targets
The COOH-terminal PDZ motifs in many NHERF targets, specifically those that bind the PDZ-I domain, contain one or more serines and threonines that are potentially phosphorylated by cellular protein kinases. An example of this is the ␤ 2 -AR, which is phosphorylated in vivo by GRK5 on a threonine residue within the COOH-terminal DTRL sequence. This reduces ␤ 2 -AR's affinity for NHERF-1 and directs the phosphorylated ␤ 2 -AR to lysosomes for degradation and downregulation (4) . These studies also suggest that NHERF-1 binds the internalized or vesicular pool of ␤ 2 -AR to promote its efficient recycling to the plasma membrane. At first sight, this paradigm appears at odds with earlier studies that showed that high con- 
Diversity of NHERF targets
NHERFs are primarily localized at or near the actin cytoskeleton underlying the plasma membrane (67) . Both NHERF proteins show unique concentration at the apical surface of polarized epithelial cells. Although the molecular basis by which NHERF proteins distinguish apical from basolateral membranes remains unknown, intracellular sorting of NHERFs appears to be an active and dynamic process, requiring microtubule function for the apical targeting of NHERFs in epithelial cells. Pharmacological disruption of microtubules in the rat kidney result in the redistribution of NHERF-1 from exclusively apical to increased basolateral localization. Biochemical studies of NHERF-1 also suggested that this adapter protein was loosely associated with membrane/cytoskeleton and other subcellular compartments and could be readily extracted in low-ionic-strength buffers (61) .
Consistent with the predominant localization of NHERFs at the cell surface, the growing list of potential NHERF targets (Table 1) shows a preponderance of membrane proteins, ion transporters, and receptors, specifically G protein-coupled receptors (GPCRs). This list may be even larger, because hormonal regulation of some membrane targets, such as NBC1 (2) and Na + -K + -ATPase (28), requires NHERF, but these proteins showed either weak or no association with the PDZ proteins. A growing number of nonmembrane targets have also been identified, arguing for a highly dynamic subcellular localization of NHERFs in mammalian cells. Interestingly, three nuclear proteins (␤-catenin, SRY-1, and transcriptional coactivator with PDZ-binding motif have been shown to bind with NHERFs, which may regulate their nuclearcytoplasmic shuttling and/or more directly facilitate their transcriptional activity. It is tempting to speculate that PDZ adapters, such as NHERFs, may aid in the recruitment and assembly of the multiprotein transcriptional complex required to activate some genes.
Interaction of NHERFS with Cellular Targets

Ligand-and second messenger-regulated NHERF binding
Although NHERFs bind some protein targets (e.g., the Na + -H + cotransporter NHE3) (26) constitutively, other interactions between NHERFs and their cellular targets are highly regulated (marked with asterisks in Table 1 ), occurring only under specific physiological conditions. For example, cellular studies suggest that there is little association of NHERF-1 with the ␤ 2 -adrenergic receptor (␤ 2 -AR) located at the plasma membrane centrations of agonists that clustered ␤ 2 -AR at clathrin-coated pits also recruited NHERF-1 (14) . Moreover, the continued presence of the agonist promoted ␤ 2 -AR internalization and its subsequent degradation or downregulation. Whether ␤ 2 -AR present in intracellular vesicles retains the bound ligand or simply possesses the conformation of a ligand-bound ␤ 2 -AR is still unclear, but the above studies (4) suggest that NHERF-1 binds internalized and unphosphorylated ␤ 2 -AR during its journey back to the plasma membrane. Once delivered to the cell surface, ␤ 2 -AR may associate either weakly or transiently with NHERF-1 and require hormonal stimulation of the receptor to strengthen its association with the PDZ adapter.
More recent studies showed that NHERF-1 was itself subject to phosphorylation by PKC within its PDZ domain. This results in its diminished association with CFTR (43) . Yet other membrane proteins are phosphorylated at serines within their PDZ motifs to yield a conformation that is more conducive to NHERF binding (17) . Thus cellular signaling pathways modulate the phosphorylation of NHERFs and their targets to regulate the association and disassociation of NHERFs with their cellular targets.
NHERF oligomerization: an expanded protein scaffold
NHERF-1 (a 58-kDa polypeptide) was isolated from renal tissues, and it demonstrated an apparent molecular size of 150 kDa (48) . This suggested that purified NHERF-1 existed as a dimer. Selfassociation of NHERF-1 as well as its ability to form NHERF-1-NHERF-2 heterodimers was established by protein overlays (9, 48) . NHERF-1 also binds another apical PDZ-domain containing adapter in the kidney, termed PDZK1 (10). The functional role of this complex in ion homeostasis is still unclear, because the PDZK1-null mice display normal serum and urinary electrolytes (24) . Although the precise function of NHERF homo-and heterodimerization is also unknown, prior studies of the Drosophila InaD protein, which contains five PDZ domains, suggest that oligomerization generated an extended submembrane scaffold that recruited multiple targets, including receptors, ion channels, and signaling proteins, to promote visual transduction in the fruit fly (8) . Recent studies indicate that a dimeric NHERF-1 may facilitate or stabilize the formation of CFTR dimers that are functionally more active ion channels (44) . Yet other studies suggested that NHERF-1 dimers stabilized the ligand-induced dimerization of PDGFR to facilitate mitogenic signaling (35) .
In vitro biochemical studies showed that the isolated NHERF-1 PDZ-I domain readily bound another PDZ-1 domain from either NHERF isoform, although weaker association with the PDZ-II domain was also noted (27). Other studies suggested that the region of NHERF-1 between PDZ-I and PDZ-II also played a role in NHERF-1 dimerization (9). Given such extensive protein-protein interactions within the NHERF-1 dimers, it was surprising that covalent modification at three serines at the COOH terminus of NHERF-1, which is not directly involved in dimerization, had both positive (27) and negative (16) effects of NHERF-1 dimerization. In this regard, NHERFs are phosphorylated by several protein kinases, including PKC (43), serum-and glucocorticoid-inducible kinase-1 (66), PKA (63), GRK6A (15) , and cyclin-dependent protein kinases (16) . Whereas mitotic phosphorylation of NHERF-1 at serines-279 and -301 inhibited NHERF-1 dimerization (16), the constitutive GRK6A-mediated phosphorylation at serine-289, when mimicked by the substitution of aspartate, enhanced NHERF-1 dimerization (27). Direct experimental evidence for an extended NHERF scaffold is still lacking, and further work will be needed to define the functional role of regulated NHERF-1 dimerization.
NHERFS and Regulation of Ion Transport
Hormonal regulation of ion transport NHERF-1 was first identified as an essential cofactor required for cAMP (and PKA) -mediated inhibition of NHE3 activity in the renal proximal tubules (61) . Subsequent studies showed that NHERF-2, present in gastric epithelia, also facilitated PKA inhibition of NHE3 when coexpressed in PS120 cells. Both NHERF-1 and NHERF-2 bridged NHE3 with a PKA-bound ezrin to facilitate cAMP-mediated phosphorylation of NHE3 and inhibition of Na + /H + exchange (60) . However, studies of isolated mouse renal proximal tubule membranes from the NHERF-1-null mouse, which still contained NHERF-2, established the complete absence of cAMP-mediated inhibition of NHE3 activity (62) , suggesting that only NHERF-1 was capable of mediating the cAMP signals that inhibited NHE3. These studies also suggested that NHERF-1 and NHERF-2 might fulfill distinct physiological functions in the mouse kidney.
The "signal complex" regulation described for NHE3 has also been demonstrated for the PKA regulation of CFTR activity. Although many elements of this model still remain to be defined, the NHERF-1-bound CFTR was more efficiently phosphorylated by an ezrin-bound PKA to increase chloride transport (51) .
Targeting and trafficking membrane proteins
Cellular studies suggested that NHERF proteins components in different cell types and rely on different physiological conditions. NHE3 and CFTR also compete for the same (NHERF-bound) ezrin-PKA complex to reciprocally regulate each other's function in response to hormones (1).
NHERFs and human disease
Alterations in human genes that encode some NHERF targets have been linked to reduced NHERF-1 binding. Thus the decreased interaction of NHERF-1 with several mutant merlins may play a role in the development of benign tumors found in human neurofibromatosis (54) . Similarly, mutations in the CFTR have been linked to decreased affinity for the NHERF-1 PDZ-I domain and may contribute to reduced targeting of the mutant CFTR proteins to the apical surface of lung and other epithelial cells as well as altered hormonal regulation of chloride transport noted in human cystic fibrosis (37, 44) . Although some mutations in CFTR result in complete loss of the COOH-terminal sequence that constitutes a PDZbinding motif, other mutant CFTRs retain an intact PDZ motif. This suggests that the context or conformation of the COOH-terminal sequence may also play a role in effective association of CFTR with NHERF-1 and/or NHERF-2. This also raises the possibility that altered expression or mutations in some of the more than 50 proposed NHERF targets and/or the NHERF proteins may contribute to human disease.
Concluding Remarks
This review focused on the NHERF family of PDZ proteins to highlight some of the key regulatory paradigms used by PDZ proteins to control ion transporters and other cellular targets (Table 1) . Emerging studies point to yet other mechanisms by which PDZ domain-containing proteins, specifically NHERFs, may either directly or indirectly regulate ion transporters. We also discussed the ability of some transporters to exchange NHERFs with other PDZ proteins to control their surface expression. Npt2a, whose surface expression and activity may be acutely regulated by NHERF-1, may demonstrate a variation on this theme. Chronic exposure to low serum phosphate that increases the expression of another PDZ protein in the kidney, PDZK1 (6), may lead to the displacement of NHERF-1, modulating Npt2a function.
Finally, the unique ability of NHERFs to target ion transporters and other proteins specifically to apical membranes remains poorly understood, as are the physiological signals that allow NHERFs to enter the nucleus and regulate genes that potentially encode transporters and other regulatory played a critical role in the surface expression of several GPCRs, including ␤ 2 -AR (4), luteinizing hormone receptor (LHR) (23) , and -opioid receptor (30). However, the mechanism by which NHERFs target or traffic these membrane proteins from intracellular endosomal sites to the plasma membrane still remains to be defined. Analysis of renal proximal tubules from the NHERF-1-null mouse showed that NHE3 was still effectively localized in the apical surface of renal proximal tubules in the mutant mouse kidney, whereas a different NHERF target, the type-2 sodiumphosphate transporter (Npt2a), was largely redistributed to internal vesicular sites (49) . The altered distribution of Npt2 may account for the significant hyperphosphaturia and reduced bone mineralization seen in the NHERF-1-null mice, which is reminiscent of human hereditary hyphosphatemic rickets also linked to the impaired Npt2a trafficking. Additional cellular studies demonstrate that NHERF-1 is required for effective cell-surface expression of Npt2a (58), whereas other studies suggest a more complex interplay between NHERF-1 and other PDZ proteins, such as PDZK1 and type II NaP i -cotransporter-associated protein 1, in the regulated trafficking of Npt2a in renal proximal tubule cells (10) . Similar interchange between CFTR-associated ligand, another PDZ protein, and NHERF-1 has been proposed to regulate the recycling and internalization of CFTR to and from the plasma membrane (5).
Bridging transporters with other NHERF targets
The presence of two closely positioned PDZ domains displaying different target specificities suggests that NHERFs can bridge two different PDZ targets to coordinate their cellular functions. Indeed, previous studies showed that NHERFs can bridge both NHE3 and CFTR with the non-PDZcontaining protein ezrin (1) . NHERF association also recruits phospholipase C␤3 in the vicinity of the storage-activated calcium channel, Trp4C, to harness calcium entry with phospholipid turnover and facilitate hormone signaling (55) . Similarly, NHERF-2 mediates the recruitment of CFTR and ROMK (Kir 1.1) to coordinate the functions of these two ion transporters (65) .
A much simpler concept is that NHERF targets may compete for binding to endogenous NHERFs and thereby modulate each other's functions that require their association with NHERFs. Thus ligand activation of ␤ 2 -AR can increase intracellular cAMP and inhibit NHE3 activity or recruit and sequester NHERF-1 to enhance NHE3 activity (14) . Such bimodal regulation of NHE3 by ␤ 2 -AR may depend on the spatial and temporal organization of these proteins. A key challenge for future studies will be to identify appropriate cellular systems and assays that will allow us to decipher the trafficking and function of NHERFs in different subcellular compartments.
In conclusion, tremendous progress has been made, particularly over the past 5 years, in identifying the cellular targets of NHERFs (Table 1) and deciphering the cellular mechanisms by which these PDZ proteins regulate ion transport (FIGURE 1). Further advances, such as the development of new genetic models and utilization of combined molecular, cellular, and physiological approaches, promises rapid progress in the understanding of NHERF functions in the years to come. 
FIGURE 1. Regulation of ion transport proteins by NHERFs
Regulatory paradigms displayed by Na + /H + exchanger regulatory factors (NHERFs) include the tethering of plasma membrane-localized ion transporters to the underlying actin cytoskeleton to stabilize or target these transporters to the cell surface and enhance their transport functions. These PDZ proteins also recruit other accessory proteins. Thus NHERFs, via their association with actin-associated ERM proteins, bridge transporters with signal transducers, such as PKA (and other kinases), to facilitate hormonal regulation of ion transport. Yet other transporters are primarily regulated by dynamic trafficking to and from the plasma membrane. The trafficking of ion transporters is also mediated by their association with NHERFs, which may cooperate to direct the endosomal pool of transporters to the plasma membrane or, in response to specific physiological stimuli, internalize the cell surface proteins and direct them to lysosomes for degradation and inactivation. Finally, growing evidence suggests that NHERFs shuttle in and out of the nucleus, where they may associate with DNA-binding proteins or transcriptional factors to promote the activation of genes that may include transporters and other regulatory proteins. Thus NHERFs orchestrate a variety of events in several subcellular compartments to both positively and negatively regulate ion transport in mammalian cells. 
